Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

2,070 evidence items · page 9 / 83

10,000,000 childrenIn Nigeria, more than 10 million children are exposed to seasonal malaria chemoprevention (SMC) medicines every year.

Nigeriapaludismepublished 2024BMC health services researchPubMeddocument of 8 observations

This study did not observe mutations associated with the in vitro resistance in southeast Asia, such as Y493H, R539T, I543T, and C580Y.

Nigeriapaludismepublished 2021Malaria journalPubMeddocument of 5 observations

71.9 %The coinfection seroprevalence of chikungunya and malaria was 71.9% among 871 participants in three regions of Nigeria.

Nigeriachikungunya · paludismepublished 2022International journal of environmental research and public healthPubMeddocument of 6 observations

87 parasites/microl bloodParasite densities ranged from 87 to 36,209 parasites/microl blood in patients from Otu.

Nigeriapaludismepublished 2004African journal of medicine and medical scienceseurope_pmcdocument of 5 observations

20.5 %The proportion of parasite genotypes with two or more mutations was 20.5% in New Bussa.

Nigeriapaludismepublished 2021Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genPubMeddocument of 16 observations

23 %By 2013, 23% of reproductive aged women surveyed in Nigeria received sulfadoxine-pyrimethamine for malaria prevention in their last pregnancy of the past 5 years.

Nigeriapaludismeobserved 2013published 2020Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument of 2 observations

56 patientsGametocytaemia was detected in 56 patients (9%) after treatment among 612 children with uncomplicated Plasmodium falciparum malaria treated with amodiaquine.

Nigeriapaludismeobserved 2000 - 2006published 2008Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/1475-2875-7-169

64 %The prevalence of the worst-case scenario (fewer than four antenatal care visits and fewer than three intermittent preventive treatment with sulfadoxine-pyrimethamine doses) was 64.0% among pregnant women in the poorest wealth quintile in Nigeria.

Nigeriapaludismeobserved 2018published 2026Malaria journalPubMeddocument of 9 observations

97.7 %Insecticide-treated net (ITN) ownership was 97.7% among rural households in Nigeria according to the 2021 Malaria Indicator Survey.

Nigeriapaludismeobserved 2021published 2025BMC public healthPubMeddocument of 4 observations

3.6 odds_ratioLow-income households in rural Nigeria had 3.6 times higher odds of insecticide-treated net (ITN) use compared to higher-income households, according to the 2021 Malaria Indicator Survey.

Nigeriapaludismeobserved 2021published 2025BMC public healthPubMeddocument of 4 observations

117 asexual forms/microlThe recrudescent parasitaemia had a geometric mean of 117 asexual forms/microl with a range of 40–9756, significantly lower than the primary infection geometric mean of 1112 (30–25,592) asexual forms/microl.

Nigeriapaludismepublished 2003Annals of tropical medicine and parasitologyeurope_pmcdocument of 4 observations

25.62 hoursMean parasite clearance time for the per-protocol population was 25.62 hours.

Nigeriapaludismepublished 2008Malaria journaleurope_pmcdocument of 10 observationsDOI 10.1186/1475-2875-7-246

0.8 µmol/litreThe IC99 of quinine against Nigerian Plasmodium falciparum isolates was 0.8 µmol per litre.

Nigeriapaludismepublished 1988Transactions of the Royal Society of Tropical Medicine and HygieneOpenAlexdocument of 5 observations

1.7 odds_ratioIn adjusted analyses, microscopy detectable gametocytemia at enrolment was associated with an increase in the odds of IgG seropositivity to Pf s230c (OR 1.70 [95% CI 1.10, 2.62], p = 0.017).

Nigeriapaludismepublished 2022Frontiers in cellular and infection microbiologyeurope_pmcdocument of 7 observations

57.1 %Women with only primary education had a malaria prevalence of 57.1%.

Nigeriapaludismepublished 2022African health sciencesPubMeddocument of 22 observations

2.86 cmMean spleen length was 2.86 ± 0.9 cm in children with asymptomatic malaria parasitaemia.

Nigeriapaludismepublished 2020Annals of global healthPubMeddocument of 9 observations

61.9 %The malaria-specific service readiness index was 61.9% among Primary Health Centres in Ekiti State.

Nigeriapaludismeobserved 2020published 2022The Pan African medical journalPubMeddocument of 5 observations

The R21/Matrix-M vaccine has significantly reduced incident malaria in children aged 3–36 months.

Nigeriapaludismepublished 2025BMC public healthPubMeddocument of 8 observations

97.1 %The sensitivity of the DLM assay for Plasmodium falciparum detection in febrile Nigerian patients was 97.1%.

Nigeriapaludismepublished 2015Journal of clinical microbiologyeurope_pmcdocument of 6 observations

23.42 %The overall prevalence of malaria was 23.42% among 316 sampled mothers in Port Harcourt, Nigeria.

Nigeriapaludismepublished 2023Journal of vector borne diseasesPubMeddocument of 8 observations

3.2 %Among Plasmodium falciparum isolates from Lagos, Nigeria, mutations were observed at codon D1246Y in 3.2%.

Nigeriapaludismepublished 2026Biochemical geneticsPubMeddocument of 16 observations

51,482 cases_per_monthThe SARIMA model forecasted average monthly malaria cases of 51,482 in Nasarawa for the period 2025–2026.

Nigeriapaludismeobserved 2025-2026published 2026PloS onePubMeddocument of 8 observations

20.2 %The Malaria Atlas Project projected a malaria prevalence of 20.2% during the dry season in the study area.

Nigeriapaludismeobserved dry seasonpublished 2020Malaria journalPubMeddocument of 6 observations

2 patientsTwo patients treated with halofantrine suffered recrudescent infections after treatment.

Nigeriapaludismepublished 1997Experimental parasitologyeurope_pmcdocument of 6 observations

78.2 %The prevalence of intermittent preventive treatment of malaria in pregnancy (IPTp) was 78.2% in the North West geopolitical zone of Nigeria.

Nigeriapaludismeobserved 2016-17published 2021PloS oneeurope_pmcdocument of 14 observationsDOI 10.1371/journal.pone.0254475

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.